Clinical trials recruiting in Piedecuesta, Colombia
6
Recruiting trials
12
Conditions
Phase breakdown
Phase 2 1Phase 3 6
Conditions recruiting in Piedecuesta, Colombia
Recruiting trials in Piedecuesta, Colombia
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
- A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Common questions
How many clinical trials are recruiting in Piedecuesta, Colombia?
6 recruiting trials have at least one study site in Piedecuesta, Colombia.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.